F. Lippi et al., Use of surgical gamma probe for the detection of lymph node metastases in differentiated thyroid cancer, TUMORI, 86(4), 2000, pp. 367-369
Background: patients with differentiated thyroid cancer (DTC) after total o
r near-total thyroidectomy require I-131 therapy. After surgery the persist
ence of lymph node metastases in our series of patients was frequent (30%).
Such patients are preferentially treated with radioiodine and shifted to s
urgical reintervention when the nodal lesions persist after two I-131 treat
ments.
Aim: Use of an intraoperative radioactive probe (C-TraK) to allow a more ra
dical surgical approach in thyroid cancer patients submitted to surgery for
lymph node metastases,
Methods and results: After adequate withdrawal of L-thyroxine suppressive t
herapy six patients were given high I-131 doses followed by post-therapy WB
S which demonstrated cervical activity in 5 patients and peri-jugular activ
ity in 1. Surgery with the help of a gamma probe allowed to detect and remo
ve all metastatic nodes. After excision all surgical specimens showed highe
r radioactive counts with respect to the background. The post-surgical scan
showed the disappearance of all areas of I-131 uptake. Histology confirmed
the presence of metastatic lesions from papillary thyroid cancer.
Conclusions: We conclude that the use of a gamma probe can be successful in
patients with metastatic neck lesions resistant to I-131 treatment, partic
ularly in patients with nonpalpable lesions.